Crystalline Management »

Fusion Pharmaceuticals shares owned by Crystalline Management

Quarter-by-quarter ownership of Fusion Pharmaceuticals (FUSN) shares owned by Crystalline Management from 13F filings

Historical chart of Crystalline Management investment in Fusion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fusion Pharmaceuticals held by Crystalline Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fusion Pharmaceuticals by Crystalline Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $239k 11k 21.32

More positions owned by Crystalline Management

Altair Engr Note 1.750% 6/1 (Principal)
Enerplus Corp (ERF)
Integer Hldgs Corp Note 2.125% 2/1 (Principal)
Mountain & Co I Acquisitn Class A Ord (MCAA)
Monterey Cap Acquisition Cor Class A Com (MCAC)
Hollysys Automation Tchngy L SHS (HOLI)
Ap Acquisition Corp Cl A Ord Shs (APCA)
Global Star Acquisition Class A Com (GLST)
Axonics Modulation Technolog (AXNX)
Ix Acquisition Corp Class A Ord Shs (IXAQ)
Tlgy Acquisition Corporation Class A Ord Shs (TLGY)
Oca Acquisition Corp Com Cl A (OCAX)
Daseke (DSKE)
Learn Cw Investment Cor Cl A Ord Shs (LCW)
Hudson Acquisition I Corp Common Stock (HUDA)

View all positions for Crystalline Management

Top funds holding Fusion Pharmaceuticals

Federated Investors
Perceptive Advisors
Avidity Partners Management
Deerfield Management Company
Fil
Pentwater Capital Management
Johnson & Johnson
Millennium Management
Tpg Gp A
TIG Advisors
FMR
Marshall Wace
Verition Fund Management
Qube Research & Technologies
William Blair $ Company

View all funds holding Fusion Pharmaceuticals